These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16545504)

  • 1. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein.
    Echeverria PC; de Miguel N; Costas M; Angel SO
    Vaccine; 2006 May; 24(19):4102-10. PubMed ID: 16545504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
    Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
    Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
    Jongert E; de Craeye S; Dewit J; Huygen K
    Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis.
    Hoseinian Khosroshahi K; Ghaffarifar F; D'Souza S; Sharifi Z; Dalimi A
    Vaccine; 2011 Jan; 29(4):778-83. PubMed ID: 21095254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii.
    Wang H; Liu Q; Liu K; Zhong W; Gao S; Jiang L; An N
    Parasitol Int; 2007 Dec; 56(4):263-8. PubMed ID: 17587637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice.
    Cui YL; He SY; Xue MF; Zhang J; Wang HX; Yao Y
    Parasite Immunol; 2008 May; 30(5):309-13. PubMed ID: 18331395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine.
    Xue M; He S; Zhang J; Cui Y; Yao Y; Wang H
    Exp Parasitol; 2008 Jul; 119(3):352-7. PubMed ID: 18442818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.
    Vercammen M; Scorza T; Huygen K; De Braekeleer J; Diet R; Jacobs D; Saman E; Verschueren H
    Infect Immun; 2000 Jan; 68(1):38-45. PubMed ID: 10603366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK; Li J; Fu TX; Bai XL; Cui Y; Zhang DB; Wang HF; Liu YB; Fu B; Zai DF; Huang BC; Liu KY; Han GD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and expression of Toxoplasma gondii surface antigen 2 (SAG2) and rhoptry protein 2 (ROP2) from recombinant Escherichia coli strain.
    Yan H; Yan H; Tao Y; Chen H; Li G; Gong W; Jiao H; Tian F; Ji M
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):356-62. PubMed ID: 22537565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
    Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
    Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.